LXRX — LEXICON PHARMACEUTICALS INC

Ownership history in EntryPoint Capital, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in LEXICON PHARMACEUTICALS INC (LXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.48% (2023 Q4)
Avg. % of fund
0.25%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 33,618 -290,350 -89.6% 0.02% $39K $1.15
2023 Q4 INITIATED 323,968 — — 0.48% $496K —
% of Fund (quarterly)    LXRX price (monthly, adj. close)

Other funds also holding LXRX

As of 2025 Q4 — sorted by position size

Artal Group S.A. 3Y 7Y 21.91% Siren, L.L.C. 1.34% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.1% Sessa Capital IM, L.P. 3Y 7Y 0.06% Hennion & Walsh Asset Management, Inc. 3Y 0.04% Monaco Asset Management SAM 3Y 0.02% Vermillion & White Wealth Management Group, LLC 0.02% Straight Path Wealth Management 3Y 0.02% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.02% Quarry LP 3Y 0.02%
← Back to EntryPoint Capital, LLC Holdings